Efficacy of various disinfectants against SARS coronavirus.
Identifieur interne : 002736 ( PubMed/Checkpoint ); précédent : 002735; suivant : 002737Efficacy of various disinfectants against SARS coronavirus.
Auteurs : H F Rabenau [Allemagne] ; G. Kampf ; J. Cinatl ; H W DoerrSource :
- The Journal of hospital infection [ 0195-6701 ] ; 2005.
Descripteurs français
- KwdFr :
- Animaux, Anti-infectieux locaux (), Anti-infectieux locaux (pharmacologie), Cellules Vero, Désinfectants (), Désinfectants (pharmacologie), Désinfection des mains (), Détergents (), Détergents (pharmacologie), Gels, Humains, Syndrome respiratoire aigu sévère (virologie), Tests de sensibilité microbienne (), Virus du SRAS (), Virus du SRAS (croissance et développement).
- MESH :
- croissance et développement : Virus du SRAS.
- pharmacologie : Anti-infectieux locaux, Désinfectants, Détergents.
- virologie : Syndrome respiratoire aigu sévère.
- Animaux, Anti-infectieux locaux, Cellules Vero, Désinfectants, Désinfection des mains, Détergents, Gels, Humains, Tests de sensibilité microbienne, Virus du SRAS.
English descriptors
- KwdEn :
- Animals, Anti-Infective Agents, Local (chemistry), Anti-Infective Agents, Local (pharmacology), Chlorocebus aethiops, Detergents (chemistry), Detergents (pharmacology), Disinfectants (chemistry), Disinfectants (classification), Disinfectants (pharmacology), Gels, Hand Disinfection (methods), Humans, Microbial Sensitivity Tests (methods), SARS Virus (drug effects), SARS Virus (growth & development), Severe Acute Respiratory Syndrome (virology), Vero Cells.
- MESH :
- chemical , chemistry : Anti-Infective Agents, Local, Detergents, Disinfectants.
- chemical , classification : Disinfectants.
- chemical , pharmacology : Anti-Infective Agents, Local, Detergents, Disinfectants.
- drug effects : SARS Virus.
- growth & development : SARS Virus.
- methods : Hand Disinfection, Microbial Sensitivity Tests.
- virology : Severe Acute Respiratory Syndrome.
- Animals, Chlorocebus aethiops, Gels, Humans, Vero Cells.
Abstract
The recent severe acute respiratory syndrome (SARS) epidemic in Asia and Northern America led to broad use of various types of disinfectant in order to control the public spread of the highly contagious virus. However, only limited data were available to demonstrate their efficacy against SARS coronavirus (SARS-CoV). We therefore investigated eight disinfectants for their activity against SARS-CoV according to prEN 14476. Four hand rubs were tested at 30s (Sterillium, based on 45% iso-propanol, 30% n-propanol and 0.2% mecetronium etilsulphate; Sterillium Rub, based on 80% ethanol; Sterillium Gel, based on 85% ethanol; Sterillium Virugard, based on 95% ethanol). Three surface disinfectants were investigated at 0.5% for 30 min and 60 min (Mikrobac forte, based on benzalkonium chloride and laurylamine; Kohrsolin FF, based on benzalkonium chloride, glutaraldehyde and didecyldimonium chloride; Dismozon pur, based on magnesium monoperphthalate), and one instrument disinfectant was investigated at 4% for 15 min, 3% for 30 min and 2% for 60 min [Korsolex basic, based on glutaraldehyde and (ethylenedioxy)dimethanol]. Three types of organic load were used: 0.3% albumin, 10% fetal calf serum, and 0.3% albumin with 0.3% sheep erythrocytes. Virus titres were determined by a quantitative test (endpoint titration) in 96-well microtitre plates. With all tested preparations, SARS-CoV was inactivated to below the limit of detection (reduction factor mostly > or =4), regardless of the type of organic load. In summary, SARS-CoV can be inactivated quite easily with many commonly used disinfectants.
DOI: 10.1016/j.jhin.2004.12.023
PubMed: 15923059
Affiliations:
- Allemagne
- District de Darmstadt, Hesse (Land)
- Francfort-sur-le-Main
- Université Johann Wolfgang Goethe de Francfort-sur-le-Main
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15923059Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficacy of various disinfectants against SARS coronavirus.</title><author><name sortKey="Rabenau, H F" sort="Rabenau, H F" uniqKey="Rabenau H" first="H F" last="Rabenau">H F Rabenau</name><affiliation wicri:level="4"><nlm:affiliation>Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Paul-Ehrlich-Strasse 40, 60596 Frankfurt, Germany. rabenau@em.uni-frankfurt.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Paul-Ehrlich-Strasse 40, 60596 Frankfurt</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Darmstadt</region><settlement type="city">Francfort-sur-le-Main</settlement></placeName><orgName type="university">Université Johann Wolfgang Goethe de Francfort-sur-le-Main</orgName></affiliation></author><author><name sortKey="Kampf, G" sort="Kampf, G" uniqKey="Kampf G" first="G" last="Kampf">G. Kampf</name></author><author><name sortKey="Cinatl, J" sort="Cinatl, J" uniqKey="Cinatl J" first="J" last="Cinatl">J. Cinatl</name></author><author><name sortKey="Doerr, H W" sort="Doerr, H W" uniqKey="Doerr H" first="H W" last="Doerr">H W Doerr</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15923059</idno><idno type="pmid">15923059</idno><idno type="doi">10.1016/j.jhin.2004.12.023</idno><idno type="wicri:Area/PubMed/Corpus">002707</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002707</idno><idno type="wicri:Area/PubMed/Curation">002707</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002707</idno><idno type="wicri:Area/PubMed/Checkpoint">002736</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002736</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Efficacy of various disinfectants against SARS coronavirus.</title><author><name sortKey="Rabenau, H F" sort="Rabenau, H F" uniqKey="Rabenau H" first="H F" last="Rabenau">H F Rabenau</name><affiliation wicri:level="4"><nlm:affiliation>Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Paul-Ehrlich-Strasse 40, 60596 Frankfurt, Germany. rabenau@em.uni-frankfurt.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Paul-Ehrlich-Strasse 40, 60596 Frankfurt</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Darmstadt</region><settlement type="city">Francfort-sur-le-Main</settlement></placeName><orgName type="university">Université Johann Wolfgang Goethe de Francfort-sur-le-Main</orgName></affiliation></author><author><name sortKey="Kampf, G" sort="Kampf, G" uniqKey="Kampf G" first="G" last="Kampf">G. Kampf</name></author><author><name sortKey="Cinatl, J" sort="Cinatl, J" uniqKey="Cinatl J" first="J" last="Cinatl">J. Cinatl</name></author><author><name sortKey="Doerr, H W" sort="Doerr, H W" uniqKey="Doerr H" first="H W" last="Doerr">H W Doerr</name></author></analytic><series><title level="j">The Journal of hospital infection</title><idno type="ISSN">0195-6701</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Anti-Infective Agents, Local (chemistry)</term><term>Anti-Infective Agents, Local (pharmacology)</term><term>Chlorocebus aethiops</term><term>Detergents (chemistry)</term><term>Detergents (pharmacology)</term><term>Disinfectants (chemistry)</term><term>Disinfectants (classification)</term><term>Disinfectants (pharmacology)</term><term>Gels</term><term>Hand Disinfection (methods)</term><term>Humans</term><term>Microbial Sensitivity Tests (methods)</term><term>SARS Virus (drug effects)</term><term>SARS Virus (growth & development)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Vero Cells</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Anti-infectieux locaux ()</term><term>Anti-infectieux locaux (pharmacologie)</term><term>Cellules Vero</term><term>Désinfectants ()</term><term>Désinfectants (pharmacologie)</term><term>Désinfection des mains ()</term><term>Détergents ()</term><term>Détergents (pharmacologie)</term><term>Gels</term><term>Humains</term><term>Syndrome respiratoire aigu sévère (virologie)</term><term>Tests de sensibilité microbienne ()</term><term>Virus du SRAS ()</term><term>Virus du SRAS (croissance et développement)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Anti-Infective Agents, Local</term><term>Detergents</term><term>Disinfectants</term></keywords><keywords scheme="MESH" type="chemical" qualifier="classification" xml:lang="en"><term>Disinfectants</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Infective Agents, Local</term><term>Detergents</term><term>Disinfectants</term></keywords><keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Hand Disinfection</term><term>Microbial Sensitivity Tests</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Anti-infectieux locaux</term><term>Désinfectants</term><term>Détergents</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Chlorocebus aethiops</term><term>Gels</term><term>Humans</term><term>Vero Cells</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Anti-infectieux locaux</term><term>Cellules Vero</term><term>Désinfectants</term><term>Désinfection des mains</term><term>Détergents</term><term>Gels</term><term>Humains</term><term>Tests de sensibilité microbienne</term><term>Virus du SRAS</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The recent severe acute respiratory syndrome (SARS) epidemic in Asia and Northern America led to broad use of various types of disinfectant in order to control the public spread of the highly contagious virus. However, only limited data were available to demonstrate their efficacy against SARS coronavirus (SARS-CoV). We therefore investigated eight disinfectants for their activity against SARS-CoV according to prEN 14476. Four hand rubs were tested at 30s (Sterillium, based on 45% iso-propanol, 30% n-propanol and 0.2% mecetronium etilsulphate; Sterillium Rub, based on 80% ethanol; Sterillium Gel, based on 85% ethanol; Sterillium Virugard, based on 95% ethanol). Three surface disinfectants were investigated at 0.5% for 30 min and 60 min (Mikrobac forte, based on benzalkonium chloride and laurylamine; Kohrsolin FF, based on benzalkonium chloride, glutaraldehyde and didecyldimonium chloride; Dismozon pur, based on magnesium monoperphthalate), and one instrument disinfectant was investigated at 4% for 15 min, 3% for 30 min and 2% for 60 min [Korsolex basic, based on glutaraldehyde and (ethylenedioxy)dimethanol]. Three types of organic load were used: 0.3% albumin, 10% fetal calf serum, and 0.3% albumin with 0.3% sheep erythrocytes. Virus titres were determined by a quantitative test (endpoint titration) in 96-well microtitre plates. With all tested preparations, SARS-CoV was inactivated to below the limit of detection (reduction factor mostly > or =4), regardless of the type of organic load. In summary, SARS-CoV can be inactivated quite easily with many commonly used disinfectants.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15923059</PMID><DateCompleted><Year>2005</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0195-6701</ISSN><JournalIssue CitedMedium="Print"><Volume>61</Volume><Issue>2</Issue><PubDate><Year>2005</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The Journal of hospital infection</Title><ISOAbbreviation>J. Hosp. Infect.</ISOAbbreviation></Journal><ArticleTitle>Efficacy of various disinfectants against SARS coronavirus.</ArticleTitle><Pagination><MedlinePgn>107-11</MedlinePgn></Pagination><Abstract><AbstractText>The recent severe acute respiratory syndrome (SARS) epidemic in Asia and Northern America led to broad use of various types of disinfectant in order to control the public spread of the highly contagious virus. However, only limited data were available to demonstrate their efficacy against SARS coronavirus (SARS-CoV). We therefore investigated eight disinfectants for their activity against SARS-CoV according to prEN 14476. Four hand rubs were tested at 30s (Sterillium, based on 45% iso-propanol, 30% n-propanol and 0.2% mecetronium etilsulphate; Sterillium Rub, based on 80% ethanol; Sterillium Gel, based on 85% ethanol; Sterillium Virugard, based on 95% ethanol). Three surface disinfectants were investigated at 0.5% for 30 min and 60 min (Mikrobac forte, based on benzalkonium chloride and laurylamine; Kohrsolin FF, based on benzalkonium chloride, glutaraldehyde and didecyldimonium chloride; Dismozon pur, based on magnesium monoperphthalate), and one instrument disinfectant was investigated at 4% for 15 min, 3% for 30 min and 2% for 60 min [Korsolex basic, based on glutaraldehyde and (ethylenedioxy)dimethanol]. Three types of organic load were used: 0.3% albumin, 10% fetal calf serum, and 0.3% albumin with 0.3% sheep erythrocytes. Virus titres were determined by a quantitative test (endpoint titration) in 96-well microtitre plates. With all tested preparations, SARS-CoV was inactivated to below the limit of detection (reduction factor mostly > or =4), regardless of the type of organic load. In summary, SARS-CoV can be inactivated quite easily with many commonly used disinfectants.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rabenau</LastName><ForeName>H F</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Paul-Ehrlich-Strasse 40, 60596 Frankfurt, Germany. rabenau@em.uni-frankfurt.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kampf</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Cinatl</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Doerr</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Hosp Infect</MedlineTA><NlmUniqueID>8007166</NlmUniqueID><ISSNLinking>0195-6701</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000891">Anti-Infective Agents, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003902">Detergents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004202">Disinfectants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005782">Gels</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000891" MajorTopicYN="N">Anti-Infective Agents, Local</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003902" MajorTopicYN="N">Detergents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004202" MajorTopicYN="N">Disinfectants</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005782" MajorTopicYN="N">Gels</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006235" MajorTopicYN="N">Hand Disinfection</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>07</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2004</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>6</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>12</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>6</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15923059</ArticleId><ArticleId IdType="pii">S0195-6701(05)00044-7</ArticleId><ArticleId IdType="doi">10.1016/j.jhin.2004.12.023</ArticleId><ArticleId IdType="pmc">PMC7132504</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Crit Care Med. 2003 Nov;31(11):2684-92</Citation><ArticleIdList><ArticleId IdType="pubmed">14605542</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Appl Microbiol. 1955 Nov;3(6):333-6</Citation><ArticleIdList><ArticleId IdType="pubmed">13269083</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hosp Infect. 2004 Apr;56 Suppl 2:S23-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15110119</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Vet Res. 1946 Oct;7(25):466-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20275301</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Jul 26;362(9380):293-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12892961</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Di Yi Jun Yi Da Xue Xue Bao. 2004 Mar;24(3):355-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15041564</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hosp Infect. 2004 Apr;56 Suppl 2:S40-3</Citation><ArticleIdList><ArticleId IdType="pubmed">15110121</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Euro Surveill. 2003 Dec 01;8(12):228-30</Citation><ArticleIdList><ArticleId IdType="pubmed">14724331</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hosp Infect. 2005 Jun;60(2):144-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15866013</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2000 Jul 22;356(9226):310</Citation><ArticleIdList><ArticleId IdType="pubmed">11071189</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 1984 Oct 20;2(8408):899-901</Citation><ArticleIdList><ArticleId IdType="pubmed">6207400</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Virol. 2004 Jan;29(1):13-22</Citation><ArticleIdList><ArticleId IdType="pubmed">14675864</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hosp Infect. 2004 Apr;56 Suppl 2:S27-39</Citation><ArticleIdList><ArticleId IdType="pubmed">15110120</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hosp Infect. 2004 Apr;56 Suppl 2:S16-22</Citation><ArticleIdList><ArticleId IdType="pubmed">15110118</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 1983 Sep;18(3):535-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6630443</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Infect Dis. 2004 Feb 15;189(4):642-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14767817</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 1984 Aug;20(2):214-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6436295</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2004 Jan 10;363(9403):99-104</Citation><ArticleIdList><ArticleId IdType="pubmed">14726162</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Bull World Health Organ. 2004 Feb;82(2):152-3</Citation><ArticleIdList><ArticleId IdType="pubmed">15042239</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Med Microbiol Immunol. 2005 Jan;194(1-2):1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15118911</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Bacteriol. 1956 Apr;71(4):491-2</Citation><ArticleIdList><ArticleId IdType="pubmed">13319266</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hosp Infect. 2004 Apr;56 Suppl 2:S58-63</Citation><ArticleIdList><ArticleId IdType="pubmed">15110125</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Infect Dis. 1985 Aug;152(2):400-3</Citation><ArticleIdList><ArticleId IdType="pubmed">2993438</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Jun 14;361(9374):2045-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12814717</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hosp Infect. 2002 Oct;52(2):141-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12392906</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biomed Environ Sci. 2003 Sep;16(3):246-55</Citation><ArticleIdList><ArticleId IdType="pubmed">14631830</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 3;361(9368):1519-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12737864</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2003 May 16;52(19):433-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12807083</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Microbiol Rev. 2004 Oct;17(4):863-93, table of contents</Citation><ArticleIdList><ArticleId IdType="pubmed">15489352</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country><region><li>District de Darmstadt</li><li>Hesse (Land)</li></region><settlement><li>Francfort-sur-le-Main</li></settlement><orgName><li>Université Johann Wolfgang Goethe de Francfort-sur-le-Main</li></orgName></list><tree><noCountry><name sortKey="Cinatl, J" sort="Cinatl, J" uniqKey="Cinatl J" first="J" last="Cinatl">J. Cinatl</name><name sortKey="Doerr, H W" sort="Doerr, H W" uniqKey="Doerr H" first="H W" last="Doerr">H W Doerr</name><name sortKey="Kampf, G" sort="Kampf, G" uniqKey="Kampf G" first="G" last="Kampf">G. Kampf</name></noCountry><country name="Allemagne"><region name="Hesse (Land)"><name sortKey="Rabenau, H F" sort="Rabenau, H F" uniqKey="Rabenau H" first="H F" last="Rabenau">H F Rabenau</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002736 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002736 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:15923059
|texte= Efficacy of various disinfectants against SARS coronavirus.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15923059" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |